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AbstrACt
Objectives Research on associations between childhood 
maltreatment and adult cardiometabolic disease 
risk is sparse. We aimed to investigate associations 
between different forms of child maltreatment and mid-
adult cardiometabolic markers and whether potential 
intermediaries could account for the associations 
observed.
setting 1958 British birth cohort.
Participants Approximately 9000 cohort members with 
data on cardiometabolic markers.
Outcomes Adult (45y) cardiometabolic markers (blood 
pressure, lipids and glycated haemoglobin [HbA1c]).
results Seventeen per cent of participants were identified 
as neglected; 6.1%, 1.6% and 10.0% were identified as 
experiencing physical, sexual and psychological abuse, 
respectively. Childhood neglect and physical abuse 
were associated with high body mass index (BMI) and 
large waist circumference when adjusting for early-life 
covariates. For neglect, the adjusted odds ratio (AOR) was 
1.16 (95% CI: 1.02 to 1.32) and 1.15 (1.02 to 1.30) for 
general and central obesity, respectively, and for physical 
abuse, the respective AOR was 1.36 (1.13 to 1.64) and 
1.38 (1.16 to 1.65). Neglect was also associated with 
raised triglycerides by 3.9 (0.3 to 7.5)% and HbA1c by 1.2 
(0.4 to 2.0)%, and among females, lower high-density 
lipoprotein cholesterol (HDL-c) by 0.05 (0.01 to 0.08)
mmol/L after adjustment. For physical abuse, the AOR 
was 1.25 (1.00 to 1.56) for high low-density lipoprotein 
cholesterol, HbA1c was raised by 2.5 (0.7 to 4.3)% (in 
males) and HDL-c was lower by 0.06 (0.01 to 0.12)mmol/L 
(in females). Associations for sexual abuse were similar 
to those for physical abuse but 95% CIs were wide. For 
psychological abuse, the AOR for elevated triglycerides 
was 1.21 (1.02 to 1.44) and HDL-c was lower by 0.04 
(0.01 to 0.07)mmol/L. Maltreatments were not associated 
with raised blood pressure. In analyses of potential 
intermediary factors, several associations attenuated after 
adjustment for adult lifestyles (mainly smoking and alcohol 
consumption rather than physical activity) and child-to-
adult BMI.
Conclusions Childhood maltreatments, particularly 
neglect and physical abuse, were associated with greater 
adiposity and poorer lipid and HbA1c profiles decades later 
in adulthood. Associations were modest but independent 
of early-life factors linked to these outcomes. Findings 
implicate adult lifestyles as an important intermediary 
between child maltreatment and outcomes.
bACkgrOund  
There is now evidence showing links between 
early-life adversities and later cardiovascular 
disease (CVD) incidence and mortality,1–3 
including some with measures of child 
maltreatment (neglect and abuse).4–8 In the 
USA, adverse childhood experiences (ACE) 
study reported child neglect or abuse was 
found to be associated with increased risk 
of self-reported ischaemic heart disease 
(OR=1.3 to 1.7 for specific forms of maltreat-
ment); the highest risk (OR=3.6, 95% CI: 2.4 
to 5.3) was found for multiple ACEs (≥7 vs 
0)5 as also seen in a more recent US study.6 
Among 33–45-year-olds in the Coronary Artery 
Risk Development in Young Adults Study, a 
one-unit increase in risky family score (range 
0–21 from self-report items) was associated 
with 1.0% higher 10-year CHD risk (using the 
Framingham algorithm).7 Mortality follow-up 
studies have shown self-reported child abuse 
to predict mortality from all causes in the 
USA,9 while those with severe (vs no) physical 
strengths and limitations of this study
 ► Data were from a population-based cohort fol-
lowed-up over five decades and included informa-
tion on a range of adult cardiometabolic measures, 
childhood maltreatment (neglect and abuse), child-
hood covariates and potential adult intermediary 
factors.
 ► Sample reductions due to missing information were 
addressed using multiple imputation.
 ► Study power for sexual abuse may be inadequate for 
detecting associations due to low prevalence.
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abuse had increased risk for CVD events (HR=1.46 [1.11 
to 1.92]) in the Nurses’ Health Study.8 Accordingly, a 
scientific statement from the American Heart Association 
identified severe childhood adversities, such as physical 
and sexual abuse, as emerging independent risk factors 
for incident ischaemic heart disease among women.10 
However, much remains unknown about child maltreat-
ment and CVD risk associations, including whether 
these are specific to different forms of maltreatment, 
whether associations are independent of other early-life 
factors and what the likely explanations or pathways are. 
Relevant to the latter is the growing evidence of child 
maltreatment and CVD risk factors, which provides 
important clues on possible intermediary pathways to 
CVD events. Investigation on a range of cardiometabolic 
biomarkers would be informative, but studies to date 
typically focus on blood pressure (BP)11–14 or obesity,15 
and rarely include blood lipids7 16 17 or glucose metab-
olism.18–20 Study findings are not always consistent; for 
example, some11 but not all12 show associations of phys-
ical or sexual abuse with raised BP. Differences in study 
design may account for such discrepancies. In particular, 
it is important to account for other early-life factors, 
such as low birth weight1 and socio-economic position 
(SEP),2 linked to these outcomes. Moreover, the litera-
ture mostly focuses on child abuse11 12 19 21 while neglect 
is often only included as a component of a combined 
measure5 18 22 despite its association with increased adult 
body mass index (BMI),23 a risk factor for the cardiomet-
abolic disease. Combined maltreatment measures may be 
useful to demonstrate cumulative effects but potentially 
obscure important differences that provide insights into 
mechanisms. Thus, two recent meta-analyses of long-term 
health consequences of non-sexual maltreatment3 or 
cumulative childhood adversity4 concluded that research 
is required to confirm relationships between all forms of 
child maltreatment, including neglect, and later chronic 
disease.
With respect to explanations or pathways, notwith-
standing a few exceptions,21 research is scarce on factors 
underlying the associations between forms of child 
maltreatment and biomarkers for adult cardiometabolic 
disease. Yet potential mechanisms can be identified, 
such as allostatic load, whereby physiological wear and 
tear over the life course24 may occur in response to child 
maltreatment and thence influence adult health. Several 
intermediary factors may be postulated. First, associa-
tions may be due to greater BMI gains21 25 or obesity11 26 
among maltreated groups. Second, child maltreatment 
may influence adult SEP,27 for example, via poorer educa-
tion level,28 which in turn affects adult health. Third, 
maltreatment may lead to risky behaviours (eg, smoking29 
or alcohol use30), which impact on disease risk. Fourth, 
the influence of maltreatment on mental health prob-
lems including depression28 could link to cardiometa-
bolic biomarkers via increased physiological response to 
stressors31 or unhealthy behaviours.3 We examined these 
potential intermediaries in a general population birth 
cohort. Our study aims were to investigate (1) whether 
different forms of childhood maltreatment (neglect 
and abuse) were associated with adult cardiometabolic 
measures (obesity, BP, blood lipids and glycated haemo-
globin) independent of other early-life factors, such 
as birth weight and SEP; and (2) whether intermediary 
factors (life-course BMI gains, adult SEP, unhealthy 
behaviours and poor mental health) could account for 
associations.
MethOds
The 1958 British birth cohort includes all births during 
one week in March 1958 (n=17 638) and 920 immigrants 
with the same birth week recruited to 16y. Information 
was collected throughout childhood (7, 11 and 16y) and 
adulthood (23, 33, 42, 45, 50 and 55y). At 45y, 11 971 indi-
viduals in contact with the study were invited to a home-
based clinical assessment; 9377 (78%) participants who 
provided information were broadly representative of the 
surviving cohort.32 The 45y survey included a childhood 
maltreatment questionnaire.
Childhood maltreatment
Information was ascertained during childhood and at 45y 
(online supplementary table S1). Neglect was prospec-
tively assessed (at ages 7 and 11y) using five questions to 
parents on their involvement with the child (infrequent 
outings and little interest in education) and to teachers 
(child’s physical appearance undernourished, scruffy or 
dirty) that correspond to conventional definitions (details 
in online supplementary table S1). A scale (range 0–5) 
was derived by summing the five indicators separately for 
each age and a binary measure was derived as ≥2 items 
(7 and/or 11y). Child abuse (physical, sexual or psycho-
logical) by a parent up to 16y (yes/no) was reported in 
adulthood (45y) in a confidential self-complete question-
naire27 (details in online supplementary table S1).
Outcomes
Cardiometabolic measurements were obtained at 45y by 
nurses using standardised protocols. Height, weight and 
waist circumference were measured; BMI was derived 
as kg/m2. BP was measured three times while seated 
after 5 minutes rest using an Omron 705CP automated 
digital oscillometric sphygmomanometer; means of three 
systolic BP (SBP) and diastolic BP (DBP) measurements 
were calculated. Non-fasting venous blood samples were 
collected and analysed for total and high-density lipopro-
tein cholesterol (HDL-c) and triglyceride concentrations 
using an autoanalyzer (Olympus AU640; Tokyo) with 
enzymatic methods. Low-density lipoprotein cholesterol 
(LDL-c) was calculated using Friedewald’s formula33 when 
triglyceride concentration was <4.5 mmol/L. Glycated 
haemoglobin (HbA1c) concentrations were measured in 
whole citrated blood using ion-exchange HPLC. Nurses 
recorded information on prescribed medications: anti-hy-
pertensive (n=429), lipid-regulating (n=166) and oral 
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glucose-lowering/antidiabetic (type 2 [T2] diabetes) 
(n=111); T2 diabetes was also identified from self-re-
ported doctor diagnosis at 42y (n=134) excluding type 1 
(T1) diabetes (n=57).
Cardiometabolic biomarkers (binary variables) were 
derived using established cutoffs (table 1) from the litera-
ture34 35 and our previous studies.36 These include general 
obesity (BMI≥30 kg/m2) and central obesity (waist 
circumference≥102 cm [males] and ≥88 cm [females]34), 
hypertension (SBP/DBP≥140/90 mmHg or anti-hyper-
tensive medication37), high triglycerides (>2.3 mmol/
L38), low HDL-c (≤1.0 mmol/L [males] and ≤1.3 mmol/L 
[females]) and high LDL-c (>4.13 mmol/L35). High 
triglycerides, low HDL-c and high LDL-c groups also 
include individuals on lipid-regulating medications. 
Elevated (≥6%) HbA1c
39 and T2 diabetes were grouped 
together, excluding T1 diabetes. Metabolic syndrome was 
defined using modified criteria of the Third Report of the 
National Cholesterol Education Program’s Adult Treat-
ment Panel35 as ≥3 of central obesity, high BP, low HDL-c, 
high triglycerides and elevated HbA1c (or T2 diabetes) as 
defined above.
Table 1 Childhood maltreatment and adult cardiometabolic biomarkers (mean [SD] or %)
N Males Females
Childhood maltreatment
  Neglect* 8734 18.9% 16.0%
  Abuse
   Physical 9309 6.0% 6.2%
   Sexual 9309 0.5% 2.7%
   Psychological 9310 8.3% 11.6%
Number of types
  0 6371 73.4% 73.5%
  1 1771 21.3% 19.5%
  2 384 4.1% 4.7%
  ≥3 150 1.2% 2.3%
Cardiometabolic markers (45y)†
  BMI (kg/m2) 9348 27.84 (4.37) 27.00 (5.64)
   General obesity (≥30 kg/m2) 25.4% 23.7%
  Waist circumference (cm) 9291 98.47 (11.24) 85.59 (12.93)
   Central obesity (≥102/88 cm)‡ 32.7% 36.9%
  Blood pressure (mmHg)
   SBP 9297 133.33 (15.35) 120.76 (16.01)
   DBP 9297 82.51 (10.84) 76.07 (10.77)
    High SBP/DBP (≥140/90) 9297 34.6% 16.3%
  Blood lipids (mmol/L)
   Total cholesterol 7824 6.10 (1.17) 5.71 (1.02)
   HDL-cholesterol 7808 1.43 (0.34) 1.69 (0.41)
    Low (≤1.0/1.3) HDL-c‡ 7847 11.8% 20.3%
   LDL-cholesterol 7391 3.60 (0.96) 3.30 (0.89)
    High (>4.13) LDL-c 7451 27.1% 15.8%
   Triglycerides 7799 2.52 (1.83) 1.60 (1.14)
    High (>2.3) triglycerides 7837 42.7% 16.7%
   HbA1c (%) 7923 5.34 (0.82) 5.20 (0.68)
    High (>6%) HbA1c 7964 6.1% 4.2%
  Metabolic syndrome 7640 15.1% 10.2%
*≥2 indicators (7 and/or 11y); sample for individuals with cardiometabolic marker(s).
†All continuous measures of cardiometabolic markers were adjusted for medication. For binary outcomes (hypertension, dyslipidemia or T2 
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Covariates
Covariates were selected a priori from the literature 
based on relationships with child maltreatment and 
adult cardiometabolic biomarkers, including factors 
affecting (measurement of) outcomes, early-life factors 
and potential intermediary factors. Early-life factors 
were all recorded prospectively at birth (birth weight 
for gestational age and childhood social class) or at age 
7y (household crowding and housing tenure). Birth 
weight for gestational age was calculated as birth weight 
(measured) standardised within each gestational week. 
Social class was based on father’s occupation at birth (or 
at 7y if missing); classified as I/II (professional/manage-
rial), IIINM (skilled non-manual), IIIM (skilled manual) 
and IV/V (semi-unskilled manual, including no male 
head). Overcrowding (≥1.5 persons per room) and social 
housing (rented from the council or housing associa-
tion vs owner-occupied or privately rented) were used as 
measures of material (dis)advantage.
Factors affecting (measurement of) outcomes at 45y 
include: measured room temperature (for BP), month of 
examination, time of day of blood collection, postal delay 
of blood sample and self-reported time since last meal 
(for lipids and HbA1c), oral contraception (10.8%) and 
HRT use (7.4%) for females (for all outcomes) and self-re-
ported family history of T2 diabetes (2.4%) (for HbA1c). 
All factors affecting the measurement of the outcome 
were included in the analysis of metabolic syndrome.
Intermediary factors for associations between maltreat-
ment and cardiometabolic markers included childhood 
(7y) and adult (45y) BMI, adult SEP (social class and 
educational qualifications), adult lifestyles (smoking, 
alcohol consumption and physical activity) and mental 
health as indexed by depressive symptoms. BMI was 
derived from measured heights and weights at ages 7y 
and 45y. Adult social class was based on the participant’s 
occupation at 42y (or at 33y if missing). Educational qual-
ifications attained by 33y was categorised into: degree/
higher, A-level, O-level, <O-level and no qualifications. 
Smoking status was reported at 42y (or at 33y if missing). 
Alcohol consumption frequency was reported at 42y, clas-
sified as: non-drinker, ≤once/month, ≤3 time/month, 
once/week, 2–3 days/week and most days. Leisure-time 
physical activity, ascertained at 42y from questions on how 
often cohort members participated in a range of activi-
ties, was categorised as: active ≤3 times/month, 1 day/
week, 2–3 days/week and 4–7 days/week.40 For depressive 
symptoms at 42y, a 0–15 scale was derived from 15 psycho-
logical items included in the Malaise Inventory.41
Analysis
Associations of each child maltreatment with continuous 
outcomes (measured by differences in mean levels) and 
binary outcomes (measured by ORs) were estimated 
using linear and logistic regressions, respectively, for 
genders combined, except where associations differed 
(p≤0.05 for gender*maltreatment interaction), which 
were analysed separately. Continuous triglycerides and 
HbA1c measures were log-transformed to correct skew-
ness of distributions; per cent change in mean level 
approximates was 100×(regression coefficient).42 Models 
included corrections for effects of medication to mini-
mise potential bias in estimates: (1) for antihyperten-
sive medication (n=429), we added a commonly used 
constant of 10 mmHg (which has been suggested on the 
basis of evidence from clinical trials) to observed SBP and 
DBP43; (2) lipid levels (n=166) were corrected assuming 
that lipid-lowering drugs reduce total cholesterol by 20%, 
LDL-c by 35%, triglycerides by 15% and increase HDL-c 
by 5%, based on the average efficacy of statins, the most 
frequently prescribed lipid-lowering drug in this study44 
and (3) for antidiabetic medication (n=111), HbA1c levels 
were corrected assuming that medication reduced HbA1c 
levels by 1% in absolute terms.45
Baseline models include gender and factors affecting 
measurements (model 1). Models were then adjusted 
for early-life factors (and, for HbA1c, family history of T2 
diabetes) (model 2) and adjusted differences in mean 
levels and adjusted OR (AOR) were estimated. For asso-
ciations that remained in model 2 (p<0.05, or border-
line for sexual abuse due to low prevalence), we further 
adjusted for potential intermediary factors. To test the 
separate and combined intermediary role of these factors, 
we examined models that further adjusted for1: BMI at 7 
and 45y,2 SEP (social class and educational qualifications),3 
lifestyle factors (smoking, alcohol consumption and phys-
ical activity),4 depressive symptoms and5 all factors simulta-
neously (models 3–7). However, conventional regression 
models with adjustment for potential mediators could 
possibly induce bias, for example, via exposure–mediator 
interactions.46 Hence, we conducted selected checks to 
ensure that associations were unaffected by such biases: (1) 
tests of maltreatment–intermediary factor interaction(s) 
that were mostly non-significant and (ii) adjustments to 
test mediator–outcome confounding: we examined effects 
on parameter estimates of additional adjustment for adult 
SEP, which is associated with both intermediary factors (eg, 
lifestyles) and cardiometabolic outcomes44; effects of such 
adjustments were negligible. As an additional check, we 
conducted a mediation analysis using inverse OR weighting 
method.47 General patterns of mediation effects were 
consistent with those obtained from regression models 3–7 
and conclusions remained unchanged. Hence, we present 
results using conventional regression with adjustment for 
mediators for simplicity of interpretation.
In addition to analyses of specific types, we exam-
ined the cumulative burden of maltreatment, as in the 
previous research5; we summed the number of types of 
maltreatment and using linear regression, examined asso-
ciations with cardiometabolic measures, with and without 
adjustment for early-life factors.
As sensitivity analyses, we examined the effects of treat-
ments (1) with adjustment for medications rather than 
using correction and (2) excluding those who were on 
treatment. Results were similar to those presented using 
correction for treatment (data not shown).
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Among participants with cardiometabolic markers 
(n=7391–9297 depending on outcome), 93% had infor-
mation on neglect and nearly all on abuse. To maximise 
available information, we applied multiple imputations to 
missing data on covariates and neglect to the sample alive 
to 45y (n=17 313). Imputation models include analysis 
variables (maltreatment, cardiometabolic markers and 
covariates) and predictors of non-response32 (gender, 
ethnicity, class at birth and 7y reading ability). We created 
25 imputed datasets assuming missing at random given 
other variables in the imputation models. Analysis samples 
were restricted to individuals with observed cardiomet-
abolic markers and abuse measures (analysis sample, 
n=7391–9297). Parameters from imputed datasets were 
combined to obtain overall estimates using Rubin’s 
rules.48 Regression models and multiple imputations by 
chained equations were conducted using SPSS (version 
24.0). Additional mediation analysis was conducted using 
STATA (version 15.0).
Patient and public involvement
Patients and the public were not involved in the design 
of the study.
results
Approximately 12.0% of participants reported any child-
hood abuse: 6.1% (physical), 1.6% (sexual) and 10.0% 
(psychological), 17.4% were classified as neglected; most 
were not maltreated, 20.4% had one and 6.1% had ≥2 
types (table 1).
Childhood neglect was associated with several cardiomet-
abolic biomarkers after adjusting for factors affecting 
measurement and early-life covariates: BMI and waist 
circumference were higher by 0.53 (95% CI:0.23 to 0.83) 
kg/m2 and 1.23 (0.51 to 1.96) cm, respectively; AORs were 
higher for both general 1.16 (1.02 to 1.32) and central 
1.15 (1.02 to 1.30) obesity and triglycerides were raised 
by 3.9 (0.3 to 7.5)% and HbA1c by 1.2 (0.4 to 2.0)%, and 
among females, HDL-c was lower by 0.05 (0.01 to 0.08)
mmol/L (table 2). When considering potential interme-
diary factors, associations reduced (mostly disappeared) 
after further adjusting for child-to-adult BMI, adult SEP 
and lifestyles (mainly smoking and alcohol consumption 
rather than physical activity) (table 3 and online supple-
mentary table S2).
Physical abuse was associated with higher BMI (by 0.72 
[0.28 to 1.16] kg/m2), waist circumference (by 1.29 [0.23 
to 2.35] cm) and obesity (AOR=1.36 [1.13 to 1.64] and 
1.38 [1.16 to 1.65] for general and central obesity, respec-
tively); increased risk of high LDL-c (AOR=1.25 [1.00 to 
1.56]), raised HbA1c in males (by 2.5 [0.7 to 4.3]%), and 
lower HDL-c in females (by 0.06 [0.01 to 0.12] mmol/L) 
(table 2). In relation to potential intermediary factors, 
associations largely attenuated when adjusting for adult 
lifestyles (notably smoking) and child-to-adult BMI (for 
HDL-c in females) except for BMI, waist circumference 
and obesity, which were unaffected (table 3 and online 
supplementary table S2). Sexual abuse associations with 
biomarkers were similar or greater in magnitude than 
other maltreatments, for example, physical abuse, but CIs 
were wide due to few cases (table 2): for example, AOR 
of high LDL-c was 1.41 (0.89 to 2.23) after adjustment 
for early-life factors and attenuating to 1.26 (0.79 to 2.00) 
when adjusting for lifestyles, predominantly smoking 
(table 3 and online supplementary table S2). Psychological 
abuse was associated with elevated risk of high triglyceride 
levels (AOR=1.21 [1.02 to 1.44]) and low HDL-c (by 0.04 
[0.01 to 0.07] mmol/L) (table 2). When considering 
potential intermediary factors, associations disappeared 
when adjusting for lifestyles (mostly smoking) and mental 
health (table 3 and online supplementary table S2).
Childhood maltreatments were not associated with 
raised BP or risk of metabolic syndrome, but since preva-
lence is low for sexual abuse, we cannot rule out elevated 
risks for either metabolic syndrome or T2 diabetes 
(table 2). Intriguingly, sexual abuse was associated with a 
reduced risk for hypertension (AOR=0.43 [0.24 to 0.74]); 
additional analysis for pulse pressure showed similar 
findings (results not presented). Whereas for other 
maltreatments, the null findings for BP, hypertension, 
metabolic syndrome or T2 diabetes are less likely to be 
due to the lack of statistical power. Finally, few associa-
tions were found between number of types of maltreat-
ment and cardiometabolic outcomes after adjusting for 
early-life factors; exceptions included BMI and elevated 
triglyceride levels, the latter reflecting weak and mostly 
non-significant associations across all maltreatment types 
(table 4 and online supplementary table S3).
disCussiOn
Main findings include, first, all forms of child maltreat-
ment were associated with at least one adverse cardiomet-
abolic outcome (adiposity, blood lipids and/or HbA1c) 
in mid-adulthood; although there was no evidence of 
adverse effects on BP. Importantly, associations were 
independent of birth weight and early-life SEP shown 
elsewhere to be associated with biomarkers for cardiomet-
abolic disease.1 2 Associations were consistent for neglect 
and physical abuse in relation to adiposity, while for other 
maltreatments and outcomes, associations were few, 
effects were modest, and evidence was weak for accumu-
lative associations for number of types of maltreatment. 
Second, in relation to potential intermediary factors for 
the child maltreatment–cardiometabolic associations 
observed, these mostly disappeared after adjusting for 
adult lifestyles, suggesting that lifestyles may play a key 
mediating role, while adult SEP was important for the 
association of neglect but not for the physical abuse with 
adiposity.
Methodological considerations
Study strengths include a population-based cohort 
followed-up over five decades, with a range of adult 
cardiometabolic measures, prospectively ascertained 
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childhood covariates including multiple indicators of 
family SEP and potential intermediary factors. Measure-
ment of childhood neglect was recorded prospectively 
from multiple sources; items related to some dimensions 
(failure to meet a child’s basic physical, emotional and 
education needs) but not all aspects (eg, inadequate 
nutrition or shelter) of neglect.49 As individual items 
may not imply neglectful behaviour, we used a score of 
≥2 items. Such measures are associated with delayed 
childhood height growth,50 cognitive ability and poorer 
qualifications,28 in this population, as expected from the 
wider literature using different study designs and thereby 
supporting construct validity for our neglect measures. 
Childhood abuse was self-reported at 45y. All ascertain-
ment methods for child maltreatment have limitations.49 
Parental report may be influenced by socially desirable 
responding and miss cases due to under-reporting, like-
wise only a small proportion of cases are identified by 
agencies. While adult report of abuse may be affected 
by recall bias or current emotional state,51 retrospec-
tive report provides an accepted method in population 
studies49; in the 1958 cohort, it was blind to knowledge 
of issues to be investigated and data show expected asso-
ciations with prospectively measured family dysfunction52 
and mental health,28 suggesting good construct validity. 
Moreover, it has been suggested that retrospective 
reports show less-biased associations with objective adult 
outcomes (such as the risk factors for cardiometabolic 
disease examined here) than self-reported outcomes.53 
Some cardiometabolic measures were collected from 
non-fasted blood. Such measures may be inappro-
priate for clinical purposes (triglycerides levels tend 
to be lower in non-fasted samples54 and vary by fasting 
duration and time of day55) but are often adequate for 
population studies given that fasting and non-fasting 
levels (eg, of triglycerides) are positively correlated56 
and because non-fasting levels have been found to be a 
significant risk factor for CVD.57 58 Moreover, misclassifi-
cation of lipid or triglyceride levels by our exposures is 
unlikely, and we adjusted for the time of last meal and 
blood collection in analyses for lipids and HbA1c. As in 
other longitudinal studies, sample attrition had occurred 
over time. Although respondents in mid-adulthood were 
generally representative of the original cohort,32 our 
previous study showed that individuals with childhood 
adversities (eg, neglect) were more likely than others 
to be lost to follow-up at 45y and thus, are under-repre-
sented in the present study.52 Although the possibility 
of attrition bias cannot be ruled out, our previous work 
on child neglect associations with other adult outcomes 
suggests that its effect is likely to be negligible,28 as also 
seen in further investigation of attrition bias in relation 
to glucose measures at 45y.59 Sample reductions due to 
missing covariates and neglect measures were addressed 
using multiple imputations. Associations between types 
of maltreatment and outcomes estimated from imputed 
data (ie, among the sample with data on outcomes at 
45y) were broadly similar to those obtained from samples 
with observed data (data not shown). Finally, study power 
for sexual abuse may be inadequate for detecting asso-
ciations due to low prevalence. Regarding methodolog-
ical approach to assess potential intermediary factors 
for maltreatment-cardiometabolic associations, we used 
conventional regression and confirmed the robustness 
Table 4 Associations (mean difference or OR) between a 




Mean difference (95% CI)†
  BMI (kg/m2) 0.33(0.17 to 0.49)
  Waist circumference (cm)
   Males 0.23 (−0.33 to 0.79)
   Females 1.14(0.57 to 1.71)
  Blood pressure
   SBP (mmHg) −0.10 (−0.61 to 0.41)
   DBP (mmHg) 0.18 (−0.17 to 0.53)
  Blood lipids
   Total cholesterol (mmol/L) 0.02 (−0.02 to 0.06)
   HDL-c (mmol/L)
    Males −0.01 (−0.03 to 0.01)
    Females −0.04 (−0.06 to –0.02)
   LDL-c 0.03 (–0.01 to 0.07)
   Triglycerides‡ (%) 2.2 (0.0 to 4.4)
  HbA1c‡ (%) 0.8 (0.4 to 1.3)
OR (95% CI) for elevated levels§
  General obesity 1.13 (1.05 to 1.21)
  Central obesity 1.12 (1.05 to 1.20)
  Hypertension 1.01 (0.94 to 1.09)
  HDL-c 1.11(1.01 to 1.21)
  LDL-c 1.05 (0.97 to 1.15)
  Triglycerides 1.10(1.01 to 1.20)
  HbA1c 1.16 (0.99 to 1.36)
  Metabolic syndrome 1.10 (0.96 to 1.26)
NB: analyses are for genders combined except where p≤0.05 for 
gender*maltreatment interaction where analyses are for males 
and females separately. Estimates that reached significance with 
p<0.05 were bold-faced. 
See also online supplementary table S3.
*Mean difference or OR estimated from model adjusted for 
gender, factors affecting measurement (for BP: measured room 
temperature; for lipids and HBA1c: examination month, time of 
blood collection, postal delay of blood sample and time since last 
meal and for females: oral contraception and HRT), family history 
of diabetes (for HbA1c, diabetes), and early-life factors, including 
birth weight for gestational age, social class at birth, housing 
tenure and crowding at 7y.
†All cardiometabolic markers (continuous measures) were adjusted 
for medication. For binary outcomes (hypertension, dyslipidemia or 
T2 diabetes), those on medication were in risk groups.
‡Log transformed and converted to per cent (NB: for HbA1c the 
parameters are per cent of the units [%]).
§Details of risk groups in table 1.
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of our conclusions using additional checks (including 
inverse OR weighting method47).
interpretation and comparison with other studies
Our main finding of few modest associations between 
types of child maltreatment and biomarkers for cardiomet-
abolic disease adds to the literature in several important 
respects. First, the adverse associations found for adult 
adiposity, blood lipids and HbA1c but not for BP, suggests 
the primary biological pathways through which some 
maltreatments could have deleterious effects on later 
cardiometabolic morbidity and mortality. These findings 
agree with others in their emphasis on adiposity15 and 
lipids/glucose,18–20 and while several studies report asso-
ciations with BP,11 13 17 not all do.12 16 One possibility is that 
some BP findings reported to date are conflated by lack 
of control for other early-life factors, a short-coming that 
we have been able to address. Moreover, others suggest, 
as we do, that associations are small to modest.7 Similar 
to our findings, the CARDIA study reported that ‘risky’ 
family environment (cold/unaffectionate family interac-
tions, conflict, aggression, neglect and low nurturance) 
was associated with HDL-c level in women, but not with 
BP.7 Specific types of maltreatment in our study, namely 
neglect and physical abuse, appeared to be particu-
larly relevant to cardiometabolic outcomes; although 
as mentioned above associations for sexual abuse were 
comparable in magnitude. Comparison with existing 
research is hindered by the dearth of studies that distin-
guish neglect from other maltreatments, but our associa-
tions of neglect and physical abuse with increased HbA1c 
(potentially T2 diabetes) agree with evidence to date18–20 
and results for physical/sexual abuse are consistent with 
an increased CVD risk for women.8 Unlike others,5 we 
found little evidence of associations for number of types 
of maltreatment, a null finding that supports the sugges-
tion of there being a few specific associations rather than 
cumulation across several types of maltreatment. Our 
findings contrast with previous research in other respects, 
for example, the lack of association for non-sexual abuse 
and metabolic syndrome (despite associations for key 
lipid and glucose components) contrasts with reported 
increased risk for physical abuse.16 21 Such discrepancies 
may arise from our null findings for BP and other consid-
erations, such as differences in design (eg, self-reported 
hypertension11 13) or in age.13 17 Associations for maltreat-
ment may vary by age, emerging later in life, as suggested 
by studies showing rapid gains in BP14 and in BMI from 
early adulthood.25
For our second main finding, results suggest that adult 
lifestyle was a key proximal intermediary factor for several 
maltreatment–biomarker associations, which concurs 
with some,5 7 8 60 though not all11 19 previous studies. Our 
interpretation of this finding is that it suggests child 
neglect and abuse are associated with higher rates of 
smoking and obesity11 25 29 that, in turn, affect cardiometa-
bolic markers, such as lipids and HbA1c. Concordant with 
our results, the US Nurses’ Health Study found that adult 
lifestyle and medical risk factors accounted for much of 
the association between child abuse and adult CVD.8 
In relation to other potential explanations, we would 
expect adult SEP to be an important factor, as reported 
elsewhere,61 especially for neglect rather than non-sexual 
abuse given its association with lower adult SEP in this 
cohort.27 Our results confirm this expectation, as several 
associations for neglect (less so for abuse) attenuated 
after allowing for adult SEP. Of the other hypothesised 
intermediary factors examined, the child-to-adult BMI 
trajectory appeared to contribute to associations for 
neglect and physical abuse with adult lipid and HbA1c 
levels. This agrees with the US Nurses’ Health Study in 
which adult BMI was found to account for most of the 
associations between physical/sexual abuse and adult T2 
diabetes.19 Lastly, for mental health, the suggestion in 
our study that this was an important pathway for psycho-
logical abuse is unsurprising. We might have expected 
it to impact other maltreatment–biomarker associations 
but found only negligible effects; although psychological 
processes other than depressive symptomatology could 
contribute.
COnClusiOns And iMPliCAtiOns
Childhood maltreatments, particularly neglect and 
physical abuse, were associated with greater adiposity 
and poorer lipid and HbA1c profiles in mid-adulthood, 
suggesting further long-term health consequences for 
these groups. Although associations were only modest; 
importantly, they were independent of main early-life 
factors (birth weight and SEP) linked previously to these 
outcomes. Study findings suggest that adult lifestyles and 
child-to-adult BMI may be key intermediaries for many 
associations, with some evidence for additional factors, 
such as adult SEP. The role of child maltreatment for 
smoking and adiposity as intermediaries linked to later 
disease is relevant to clinicians and policymakers aiming 
to reduce later consequences associated with child 
maltreatment. However, whether these intermediary risk 
factors among child maltreatment groups would benefit 
from standard interventions (eg, for smoking cessation) 
in adulthood remains to be answered. Such interventions 
may be ineffective; for example, the propensity to smoke 
or gain BMI is biologically embedded from an early age 
and difficult to alter thereafter. This would strengthen 
further the need to develop strategies for preventing 
childhood maltreatment (eg, early home visiting or 
parenting programmes targeting those at risk for child 
abuse and neglect). Further work is needed on the role of 
life-course intermediary factors to better understand the 
pathways and mechanisms underlying maltreatments–
cardiometabolic disease associations, including consider-
ation of different as well as common pathways for specific 
maltreatments. These efforts are essential to effective 
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